Bcl-3 expression in hepatocytes lowered the resistance against DEN/PB-induced apoptotic cell death, increasing the rate of cellular injury during the early phase of HCC initiation and through this potentially diminished the number of transformed cells. This evidence concerns the gene BCL3 and hepatocellular carcinoma.